A critical breakthrough in cancer study is occurring with the use of VHH fragments to re-engage dysfunctional p53. This crucial malignant protector protein is frequently disabled in various kinds of malignancies, https://bookmarklayer.com/story21998452/nanobodies-reactivate-the-p53-protein-a-new-approach-for-tumor-treatment